Schedule of operating segments (Details) - USD ($)
|
12 Months Ended |
Mar. 31, 2026 |
Mar. 31, 2025 |
Mar. 31, 2024 |
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
$ 4,856,320
|
$ 3,371,037
|
$ 2,403,552
|
| Profit/(Loss) from operations |
(2,030,859)
|
(2,480,893)
|
(2,355,731)
|
| Finance costs |
(50,459)
|
(48,283)
|
(42,844)
|
| Profit/(Loss) before tax |
(2,081,318)
|
(2,529,176)
|
(2,398,575)
|
| Income tax expense |
(5,137)
|
(95,562)
|
7,414
|
| Loss for the financial year |
(2,086,455)
|
(2,624,738)
|
(2,391,161)
|
| Segment assets |
6,969,390
|
7,133,637
|
|
| Amortisation of right-of-use assets |
474,871
|
500,144
|
403,019
|
| Additional of property, plant and equipment |
56,413
|
83,772
|
221,317
|
| Depreciation of property, plant and equipment |
481,173
|
465,287
|
455,613
|
| Finance income |
3,856
|
123
|
|
| Finance costs |
50,459
|
48,283
|
42,844
|
| Share of results in associates |
14,449
|
(10,760)
|
3,421
|
| Segment liabilities |
10,199,391
|
8,249,553
|
|
| Depreciation of property, plant and equipment |
|
|
14,083
|
| Elimination of intersegment amounts [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
(793,530)
|
(736,233)
|
(652,366)
|
| Profit/(Loss) from operations |
(4,131)
|
|
|
| Finance costs |
6,704
|
|
|
| Profit/(Loss) before tax |
2,573
|
|
|
| Income tax expense |
|
|
|
| Loss for the financial year |
2,573
|
|
|
| Segment assets |
(13,695,022)
|
(8,892,075)
|
(6,543,765)
|
| Segment liabilities |
(13,509,469)
|
|
|
| Amortisation of intangible assets |
|
|
|
| Amortisation of right-of-use assets |
(46,935)
|
|
|
| Additional of property, plant and equipment |
|
|
|
| Depreciation of property, plant and equipment |
|
|
|
| Finance income |
|
|
|
| Finance costs |
(6,704)
|
|
|
| Share of results in associates |
|
|
|
| Other material non cash items |
|
|
|
| Segment liabilities |
|
(8,666,225)
|
(6,383,376)
|
| Depreciation of property, plant and equipment |
|
|
|
| Operating segments [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
4,856,320
|
3,371,037
|
2,403,552
|
| Profit/(Loss) from operations |
(2,030,859)
|
(2,480,893)
|
(2,355,731)
|
| Finance costs |
(50,459)
|
(48,283)
|
(42,844)
|
| Profit/(Loss) before tax |
(2,081,318)
|
(2,529,176)
|
(2,398,575)
|
| Income tax expense |
(5,137)
|
(95,562)
|
7,414
|
| Loss for the financial year |
(2,086,455)
|
(2,624,738)
|
(2,391,161)
|
| Segment assets |
6,969,390
|
7,133,637
|
6,700,933
|
| Segment liabilities |
10,199,391
|
|
|
| Amortisation of intangible assets |
173,451
|
163,093
|
44,807
|
| Amortisation of right-of-use assets |
474,871
|
500,144
|
403,019
|
| Additional of property, plant and equipment |
56,413
|
83,772
|
455,613
|
| Depreciation of property, plant and equipment |
481,173
|
465,287
|
|
| Finance income |
(3,865)
|
(123)
|
|
| Finance costs |
50,459
|
48,283
|
42,844
|
| Share of results in associates |
(14,449)
|
10,760
|
(3,421)
|
| Other material non cash items |
(951,708)
|
|
|
| Segment liabilities |
|
8,249,553
|
5,249,941
|
| Depreciation of property, plant and equipment |
|
|
14,083
|
| Medical and wellness segments [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
4,609,958
|
3,396,367
|
2,577,255
|
| Profit/(Loss) from operations |
240,038
|
32,555
|
(381,848)
|
| Finance costs |
(25,509)
|
(22,825)
|
(6,944)
|
| Profit/(Loss) before tax |
214,529
|
9,730
|
(388,792)
|
| Income tax expense |
(4,724)
|
(93,487)
|
7,414
|
| Loss for the financial year |
209,805
|
(83,757)
|
(381,378)
|
| Segment assets |
2,539,043
|
2,507,576
|
1,888,659
|
| Segment liabilities |
3,333,502
|
|
|
| Amortisation of intangible assets |
35
|
|
31
|
| Amortisation of right-of-use assets |
215,529
|
199,618
|
141,762
|
| Additional of property, plant and equipment |
12,119
|
35,675
|
67,906
|
| Depreciation of property, plant and equipment |
58,695
|
58,580
|
|
| Finance income |
|
|
|
| Finance costs |
25,509
|
22,825
|
6,944
|
| Share of results in associates |
|
|
|
| Other material non cash items |
37,503
|
|
|
| Segment liabilities |
|
3,432,954
|
2,676,331
|
| Depreciation of property, plant and equipment |
|
|
14,083
|
| Life science segments [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
939,747
|
613,490
|
393,419
|
| Profit/(Loss) from operations |
(972,776)
|
(977,212)
|
(1,130,176)
|
| Finance costs |
(22,908)
|
(6,253)
|
(12,240)
|
| Profit/(Loss) before tax |
(995,684)
|
(983,465)
|
(1,142,416)
|
| Income tax expense |
(413)
|
(2,075)
|
|
| Loss for the financial year |
(996,097)
|
(985,540)
|
(1,142,416)
|
| Segment assets |
3,457,093
|
3,628,762
|
2,893,474
|
| Segment liabilities |
8,281,804
|
|
|
| Amortisation of intangible assets |
|
|
|
| Amortisation of right-of-use assets |
142,563
|
121,530
|
117,110
|
| Additional of property, plant and equipment |
5,238
|
41,989
|
370,197
|
| Depreciation of property, plant and equipment |
398,211
|
386,024
|
|
| Finance income |
|
|
|
| Finance costs |
22,908
|
6,253
|
12,240
|
| Share of results in associates |
|
|
|
| Other material non cash items |
63,638
|
|
|
| Segment liabilities |
|
7,084,309
|
5,194,755
|
| Depreciation of property, plant and equipment |
|
|
|
| All other segments [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
100,145
|
97,413
|
85,244
|
| Profit/(Loss) from operations |
(1,293,990)
|
(1,536,236)
|
(843,707)
|
| Finance costs |
(8,746)
|
(19,205)
|
(23,660)
|
| Profit/(Loss) before tax |
(1,302,736)
|
(1,555,441)
|
(867,367)
|
| Income tax expense |
|
|
|
| Loss for the financial year |
(1,302,736)
|
(1,555,441)
|
(867,367)
|
| Segment assets |
14,688,276
|
9,889,374
|
8,462,565
|
| Segment liabilities |
12,093,554
|
|
|
| Amortisation of intangible assets |
173,416
|
163,093
|
44,776
|
| Amortisation of right-of-use assets |
163,714
|
178,996
|
144,147
|
| Additional of property, plant and equipment |
39,056
|
6,108
|
17,510
|
| Depreciation of property, plant and equipment |
23,997
|
20,683
|
|
| Finance income |
(3,865)
|
(123)
|
|
| Finance costs |
8,746
|
19,205
|
23,660
|
| Share of results in associates |
(14,449)
|
10,760
|
(3,421)
|
| Other material non cash items |
(1,052,849)
|
|
|
| Segment liabilities |
|
6,398,515
|
3,762,231
|
| Depreciation of property, plant and equipment |
|
|
|
| External sales [member] | Elimination of intersegment amounts [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
|
|
|
| External sales [member] | Operating segments [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
4,856,320
|
3,371,037
|
2,403,552
|
| External sales [member] | Medical and wellness segments [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
4,496,766
|
3,353,006
|
2,390,113
|
| External sales [member] | Life science segments [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
344,518
|
1,824
|
523
|
| External sales [member] | All other segments [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
15,036
|
16,207
|
12,916
|
| Inter segment sales [member] | Elimination of intersegment amounts [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
(793,530)
|
(736,233)
|
(652,366)
|
| Inter segment sales [member] | Operating segments [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
|
|
|
| Inter segment sales [member] | Medical and wellness segments [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
113,192
|
43,361
|
187,142
|
| Inter segment sales [member] | Life science segments [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
595,229
|
611,666
|
392,896
|
| Inter segment sales [member] | All other segments [member] |
|
|
|
| IfrsStatementLineItems [Line Items] |
|
|
|
| Total revenue |
$ 85,109
|
$ 81,206
|
$ 72,328
|